×
About 103,855 results

ALLMedicine™ Hepatitis Center

Research & Reviews  35,559 results

Significance of anti-HBc serological status in primary immune thrombocytopenia.
https://doi.org/10.1111/bjh.17977
British Journal of Haematology; Wang L, Li L et. al.

Dec 3rd, 2021 - The association of previous hepatitis B virus (HBV) exposure [hepatitis B surface antigen (HBsAg) negative, hepatitis B core antibody (anti-HBc/HBcAb) positive] with disease severity and decision on treatment option in primary immune thrombocytope...

Prevention of viral infections in solid organ transplant recipients in the era of COVID...
https://doi.org/10.1080/14787210.2022.2013808
Expert Review of Anti-infective Therapy; Filippidis P, Vionnet J et. al.

Dec 3rd, 2021 - In solid organ transplant (SOT) recipients, viral infections are associated with direct morbidity and mortality and may influence long-term allograft outcomes. Prevention of viral infections by vaccination, antiviral prophylaxis, and behavioral me...

Immune-Mediated Diseases Associated With Cancer Risks.
https://doi.org/10.1001/jamaoncol.2021.5680
JAMA Oncology; He MM, Lo CH et. al.

Dec 3rd, 2021 - Immune regulation is important for carcinogenesis; however, the cancer risk profiles associated with immune-mediated diseases need further characterization. To assess the prospective association of 48 immune-mediated diseases with the risk of tota...

Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese popu...
https://doi.org/10.1002/ijc.33891
International Journal of Cancer; Liu T, Song C et. al.

Dec 3rd, 2021 - This study aims to explore the relationship between chronic hepatitis B virus (HBV) infection and the risk of gastrointestinal (GI) cancers including liver, gastric, gallbladder or extrahepatic bile duct, pancreatic, small intestine, esophageal, a...

see more →

Guidelines  97 results

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...

Non-invasive diagnosis and follow-up of autoimmune hepatitis.
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.

Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/art.41776
Arthritis & Rheumatology (Hoboken, N.J.); Chung SA, Gorelik M et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, interv...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/acr.24633
Arthritis Care & Research; Chung SA, Gorelik M et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, interv...

see more →

Drugs  400 results see all →

Clinicaltrials.gov  1,525 results

Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for the Treatment of Liver Cancer After Progression on Prior PD-1 Inhibition
https://clinicaltrials.gov/ct2/show/NCT04430452

Dec 3rd, 2021 - PRIMARY OBJECTIVE: I. Determine objective response rate (ORR) of durvalumab (D) and D + tremelimumab (T) after radiation therapy (RT) in advanced hepatocellular carcinoma (HCC) patients with progression on prior PD-1 immune checkpoint inhibitor. S...

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
https://clinicaltrials.gov/ct2/show/NCT04145141

Dec 3rd, 2021 - Background: Primary liver cancer (PLC) is the 2nd most common cause of cancer-related death worldwide and the one cancer with the fastest rising incidence and mortality in the U.S. PLC consists of two main histological subtypes, i.e., hepatocellul...

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
https://clinicaltrials.gov/ct2/show/NCT04980482

Dec 1st, 2021 - This is a randomized, open label, multicenter Phase 2 study investigating the safety and antiviral activity of AB-729 in combination with ongoing NA therapy and short courses of Peg-IFNα-2a in subjects with CHB.

Screening Protocol for the Evaluation of Potential Research Subjects
https://clinicaltrials.gov/ct2/show/NCT01036971

Nov 30th, 2021 - This protocol describes the screening process used by the National Institute on Drug Abuse (NIDA IRP) to assess potential research participants' eligibility for entering protocols of the NIDA/IRP. Through its clinical research protocols, the IRP a...

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea
https://clinicaltrials.gov/ct2/show/NCT02951364

Nov 29th, 2021 - The primary objective of this post-marketing surveillance study is to collect and assess data related to the safety and effectiveness of Harvoni® (ledipasvir/sofosbuvir (LDV/SOF)) treatment regimen, per the approved Korea prescribing information f...

see more →

News  3,888 results

New Type of Hepatitis B Vaccine OK'd
https://www.medpagetoday.com/gastroenterology/hepatitis/95983

Dec 2nd, 2021 - The FDA approved the first three-antigen hepatitis B vaccine (PreHevbrio) to prevent infection from all known subtypes in adults, VBI Vaccines announced on Wednesday. Approval for the recombinant vaccine -- which contains the S, pre-S1, and pre-S2...

Liver Cancer Risk Lingers Even After HCV Eradication
https://www.medscape.com/viewarticle/963101

Nov 17th, 2021 - Although the risk for liver cancer diminishes for patients with hepatitis C virus (HCV) infections for whom virus is eliminated with direct-acting antiviral (DAA) drugs, these patients are not out of the woods, and those who do not have a sustaine...

Age, Geography Predict COVID-19 Vaccination of Vets With Cirrhosis
https://www.medscape.com/viewarticle/963021

Nov 16th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Vaccination against SARS-CoV-2 infection can protect patients with liver cirrhosis from decompensation, hospitalization, and death, but getting th...

Low-Urgency Heart Transplant Recipients More Likely to Receive Organs From Higher-Risk Donors
https://www.medscape.com/viewarticle/962934

Nov 16th, 2021 - NEW YORK (Reuters Health) - Heart-transplant recipients with the lowest medical urgency receive hearts from donors with an increased number of comorbidities, including hepatitis C and diabetes, compared with higher-urgency patients, according to n...

Skyrocketing Demand for Liver Transplant Among Older Americans
https://www.medscape.com/viewarticle/962947

Nov 16th, 2021 - NEW YORK (Reuters Health) - Over the past two decades, the need for liver transplant (LT) in older adults has risen sharply, due to rising rates of nonalcoholic steatohepatitis (NASH), and the outcomes of LT in these patients has been improving, a...

see more →

Patient Education  73 results see all →